OCT 02, 2019 07:41 AM PDT

Triple Drug Combo Extends Fruit Fly Lifespan

WRITTEN BY: Nouran Amin

A study published in the Proceedings of the National Academy of Sciences (PNAS) suggests that a triple drug combination can extend the lifespan of a fruit fly (Drosphila) by 48%. "As life expectancy increase, we are also seeing an increase of age-related diseases so there is an urgent need to find ways to improve health in old age," said the study's co-lead author, Dr. Jorge Castillo-Quan, who began the research at the UCL Institute of Healthy Ageing before moving to Joslin Diabetes Center, Harvard Medical School.

Learn more about the Drosophila life cycle:

These drugs include lithium as a mood stabilizer, trametinib used for cancer treatment and rapamycin used to regulate the immune system—all of which act on different cellular ageing pathways. Decision upon choosing these drugs were a result of preliminary evidence in mice, worms, and cells, and observational findings in people.

"Here, by studying fruit flies which age much more rapidly than people, we have found that a combination drug treatment targeting different cellular processes may be an effective way to slow down the ageing process,” adds Dr. Castillo-Quan. "Previous studies in fruit flies have achieved lifespan extensions of about 5-20%, so we found it was quite remarkable that this drug combination enabled them to live 48% longer.”

Findings showed, that in particular, rapamycin has undesirable effects on fat metabolism which is similar to insulin resistance in people. However, lithium has cancelled out these effects when these two drugs were given together.

"There is a growing body of evidence that polypills -- pills that combine low doses of multiple pharmaceutical products -- could be effective as a medication to prevent age-related diseases, given the complex nature of the ageing process. This may be possible by combining the drugs we're investigating with other promising drugs, but there is a long way to go before we will be able to roll out effective treatments,” says principal investigator and Professor Linda Partridge (UCL Institute of Health Ageing and Max Planck Institute for Biology of Ageing).

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 17, 2019
Cell & Molecular Biology
OCT 17, 2019
Relieving a Mechanism That Could Underlie as Many as 20 Rare Disorders
Toxic proteinopathies are a group of inherited diseases that are caused when improperly folded proteins accumulate in the cell....
OCT 17, 2019
Drug Discovery & Development
OCT 17, 2019
Can LSD Treat Addiction?
Modern medicine commonly refers to addiction as a brain disease caused by drugs and other negative stimuli. However, evidence is surmounting that addiction...
OCT 17, 2019
Genetics & Genomics
OCT 17, 2019
New Gene Editing Technology to Combat Hereditary Diseases
Until recently, many types of gene-editing methods were unable to target critical parts of DNA. Now however, researchers at the Salk Institute have develop...
OCT 17, 2019
Drug Discovery & Development
OCT 17, 2019
How Does Ketamine Treat Depression?
In recent years, ketamine has received growing interest for its neuroprotective effects. Known to alleviate symptoms of depression in just hours whereas co...
OCT 17, 2019
Infographics
OCT 17, 2019
Surface Plasmon Resonance (SPR) Technology
Surface plasmon resonance (SPR) allows researchers to investigate different types of biomolecular interactions and mechanisms in real-time and label-free....
OCT 17, 2019
Microbiology
OCT 17, 2019
The Antimicrobial Power of Mucus is Revealed
We produce several liters of mucus every day to cover more than 200 square meters in the human body....
Loading Comments...